Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

March 1, 2012; Volume 53,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Atkins, Frank B.

    1. You have access
      Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PET
      Douglas Van Nostrand, Gauri R. Khorjekar, Jeff O'Neil, Shari Moreau, Frank B. Atkins, Pejman Kharazi, Mihriye Mete, Shyam P. Chennupati, Kenneth D. Burman and Leonard Wartofsky
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 359-362; DOI: https://doi.org/10.2967/jnumed.111.096016
  2. Bading, James R.

    1. You have access
      Kinetic Analysis of 18F-FLT PET in Lung Tumors
      James R. Bading
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 506; DOI: https://doi.org/10.2967/jnumed.111.097816
  3. Bartenstein, Peter

    1. You have access
      18F-FDG PET/CT Predicts Survival After Radioembolization of Hepatic Metastases from Breast Cancer
      Alexander R. Haug, Beauclair P. Tiega Donfack, Christoph Trumm, Christoph J. Zech, Marlies Michl, Rüdiger Paul Laubender, Christopher Uebleis, Peter Bartenstein, Volker Heinemann and Marcus Hacker
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 371-377; DOI: https://doi.org/10.2967/jnumed.111.096230
  4. Barth, Vanessa N.

    1. You have access
      Brain and Whole-Body Imaging of Nociceptin/Orphanin FQ Peptide Receptor in Humans Using the PET Ligand 11C-NOP-1A
      Talakad G. Lohith, Sami S. Zoghbi, Cheryl L. Morse, Maria F. Araneta, Vanessa N. Barth, Nancy A. Goebl, Johannes T. Tauscher, Victor W. Pike, Robert B. Innis and Masahiro Fujita
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 385-392; DOI: https://doi.org/10.2967/jnumed.111.097162
  5. Bengel, Frank M.

    1. You have access
      PET/CT Assessment of Symptomatic Individuals with Obstructive and Nonobstructive Hypertrophic Cardiomyopathy
      Paco E. Bravo, Aurélio Pinheiro, Takahiro Higuchi, Christoph Rischpler, Jennifer Merrill, Miguel Santaularia-Tomas, M. Roselle Abraham, Richard L. Wahl, Theodore P. Abraham and Frank M. Bengel
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 407-414; DOI: https://doi.org/10.2967/jnumed.111.096156
  6. Bravo, Paco E.

    1. You have access
      PET/CT Assessment of Symptomatic Individuals with Obstructive and Nonobstructive Hypertrophic Cardiomyopathy
      Paco E. Bravo, Aurélio Pinheiro, Takahiro Higuchi, Christoph Rischpler, Jennifer Merrill, Miguel Santaularia-Tomas, M. Roselle Abraham, Richard L. Wahl, Theodore P. Abraham and Frank M. Bengel
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 407-414; DOI: https://doi.org/10.2967/jnumed.111.096156
  7. Brockenbrough, James Scott

    1. You have access
      Reply: Kinetic Analysis of 18F-FLT PET in Lung Tumors
      James Scott Brockenbrough and Hubert Vesselle
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 506-507; DOI: https://doi.org/10.2967/jnumed.111.097873
  8. Burman, Kenneth D.

    1. You have access
      Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PET
      Douglas Van Nostrand, Gauri R. Khorjekar, Jeff O'Neil, Shari Moreau, Frank B. Atkins, Pejman Kharazi, Mihriye Mete, Shyam P. Chennupati, Kenneth D. Burman and Leonard Wartofsky
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 359-362; DOI: https://doi.org/10.2967/jnumed.111.096016
  9. Burns, Jason D.

    1. You have access
      Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
      Abhinay D. Joshi, Michael J. Pontecorvo, Chrisopher M. Clark, Alan P. Carpenter, Danna L. Jennings, Carl H. Sadowsky, Lee P. Adler, Karel D. Kovnat, John P. Seibyl, Anupa Arora, Krishnendu Saha, Jason D. Burns, Mark J. Lowrey, Mark A. Mintun, Daniel M. Skovronsky and the Florbetapir F 18 Study Investigators
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 378-384; DOI: https://doi.org/10.2967/jnumed.111.090340
  10. Carpenter, Alan P.

    1. You have access
      Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
      Abhinay D. Joshi, Michael J. Pontecorvo, Chrisopher M. Clark, Alan P. Carpenter, Danna L. Jennings, Carl H. Sadowsky, Lee P. Adler, Karel D. Kovnat, John P. Seibyl, Anupa Arora, Krishnendu Saha, Jason D. Burns, Mark J. Lowrey, Mark A. Mintun, Daniel M. Skovronsky and the Florbetapir F 18 Study Investigators
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 378-384; DOI: https://doi.org/10.2967/jnumed.111.090340
« Previous (Pages : 1 2 3 4 5 6 7 ... 19) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 53 (3)
Journal of Nuclear Medicine
Vol. 53, Issue 3
March 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Impact of 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
  • Bringing Physiology into PET of the Liver
  • Experimental Radionuclide Therapy of HER2-Expressing Xenografts Using Two-Step Targeting Nuclisome Particles
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire